Showing 1,001 - 1,020 results of 1,095 for search '"Peking University"', query time: 0.05s Refine Results
  1. 1001
  2. 1002
  3. 1003
  4. 1004
  5. 1005
  6. 1006
  7. 1007
  8. 1008
  9. 1009
  10. 1010
  11. 1011
  12. 1012

    Impact of White Blood Cell Count After Percutaneous Coronary Intervention on Long-Term Prognosis in Patients with Unstable Angina Pectoris: A Single-Center Retrospective Observatio... by Zhang Z, Wang H, Wang R, She Z, Liang X, Liu H, Kou X, Wang S

    Published 2025-01-01
    “…Zhiyuan Zhang,1– 3,* Heyan Wang,4,* Ruiyu Wang,5 Zeyu She,6 Xingyue Liang,6 Huiyi Liu,7 Xuemeng Kou,1 Shipeng Wang1– 3 1Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, People’s Republic of China; 2Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, Heilongjiang Province, People’s Republic of China; 3State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin, Heilongjiang Province, People’s Republic of China; 4Department of Cardiology, Central Hospital of Dalian University of Technology, Dalian, Liaoning Province, People’s Republic of China; 5Department of Cardiology, the First Affiliated Hospital of Medical School, Xi’an Jiaotong University, Xi’an, Shaanxi Province, People’s Republic of China; 6School of Basic Medicine, Harbin Medical university, Harbin, Heilongjiang Province, People’s Republic of China; 7Department of Cardiology, the First Affiliated Hospital of Peking University, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Shipeng Wang, Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150086, People’s Republic of China, Tel +86 13654504286, Fax +86 86296225, Email guoyunqaz@126.comObjective: An association between white blood cell count (WBC-C) before percutaneous coronary intervention (PCI) and prognosis has been established in patients undergoing PCI. …”
    Get full text
    Article
  13. 1013
  14. 1014
  15. 1015

    Non-Luminal Disease Score for Everolimus in Patients with Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Mult... by Tan Y, Jiang H, Tian X, Ma F, Wang J, Zhang P, Xu B, Fan Y, Zhao W

    Published 2025-01-01
    “…Yujing Tan,1,* Hanfang Jiang,2,* Xinzhu Tian,1,* Fei Ma,1 Jiayu Wang,1 Pin Zhang,1 Binghe Xu,1 Ying Fan,1 Weihong Zhao3 1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, People’s Republic of China; 2Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, People’s Republic of China; 3Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ying Fan; Weihong Zhao, Email fanying@cicams.ac.cn; zhaowh0818@163.comPurpose: This study aims to explore the role of the non-luminal disease score (NOLUS) for everolimus in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC).Methods: NOLUS has previously been established as an algorithm: NOLUS (0– 100) = − 0.45 × ER(%) − 0.28 × PR(%) + 0.27 × Ki67(%) + 73. …”
    Get full text
    Article
  16. 1016
  17. 1017
  18. 1018
  19. 1019
  20. 1020